🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Alibaba gains 7% as Ant Group wins approval to raise $1.5 billion

Published 01/04/2023, 06:33 AM
Updated 01/04/2023, 06:38 AM
© Reuters.  Alibaba (BABA) gains 7% as Ant Group wins approval to raise $1.5 billion
BABA
-

By Senad Karaahmetovic

Shares of Alibaba (NYSE:BABA) are up about 7% in pre-market after its Ant Group received a green light from Chinese regulators to raise $1.5 billion for its consumer unit. Alibaba owns a roughly 33% stake in Ant Group.

According to a notice on December 30 issued by the China Banking and Insurance Regulatory Commission (CBIRC), Ant can increase its capital to CNY 18.5B ($2.7B).

Ant contributed CNY 5.25B and will control half of its shares after the deal. Another entity, controlled by the city of Hangzhou, will become the second biggest shareholder with a 10% stake. Sunny Optical Technology Group Co. and Jiangsu Yuyue Medical Equipment & Supply Co. are mentioned by Bloomberg as other new investors.

The approval signals the improving relationship between China’s e-commerce behemoth and regulators. Ant is now expected to make continued progress as it looks to recover from the failed initial public offering (IPO) in 2020.

“We view it as a signal on Ant’s regulatory rectification wrap-up,” said Leon Qi, an analyst with Daiwa Capital Markets Hong Kong, according to Bloomberg.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.